A randomized trial of extra‐amniotic saline infusion versus laminaria for cervical ripening

A. Lin,M. Kupferminc,S. Dooley

DOI: https://doi.org/10.1016/S0020-7292(96)90120-4

1995-10-01

Obstetrics and Gynecology

Abstract:

What problem does this paper attempt to address?

Self-assembling materials for therapeutic delivery.

M. Branco,J. Schneider

DOI: https://doi.org/10.1016/j.actbio.2008.09.018

IF: 10.633

2009-03-01

Acta Biomaterialia

Abstract:
A methodology for the selection and characterization of riboflavin-overproducing Weissella cibaria strains after treatment with roseoflavin

Iñaki Diez-Ozaeta,Lucía Martín-Loarte,Mari Luz Mohedano,Mercedes Tamame,José Ángel Ruiz-Masó,Gloria del Solar,María Teresa Dueñas,Paloma López

DOI: https://doi.org/10.3389/fmicb.2023.1154130

IF: 5.2

2023-04-07

Frontiers in Microbiology

Abstract:Fermentative processes by lactic acid bacteria can produce metabolites of interest to the health and food industries. Two examples are the production of B-group vitamins, and of prebiotic and immunomodulatory dextran-type exopolysaccharides. In this study, three riboflavin- and dextran-producing Weissella cibaria strains (BAL3C-5, BAL3C-7 and BAL3C-22) were used to develop a new method for selection and isolation of spontaneous riboflavin-overproducing W. cibaria mutants. This method was based on the selection of strains resistant to roseoflavin. The DNA sequencing of the FMN riboswitch of bacterial cell populations treated with various roseoflavin concentrations, revealed the existence of at least 10 spontaneous and random point mutations at this location. Folding and analysis of the mutated FMN riboswitches with the RNA fold program predicted that these mutations could result in a deregulation of the rib operon expression. When the roseoflavin-treated cultures were plated on medium supporting dextran synthesis, the most promising mutants were identified by the yellow color of their mucous colonies, exhibiting a ropy phenotype. After their isolation and recovery in liquid medium, the evaluation of their riboflavin production revealed that the mutant strains synthesized a wide range of riboflavin levels (from 0.80 to 6.50 mg/L) above the wild-type level (0.15 mg/L). Thus, this was a reliable method to select spontaneous riboflavin-overproducing and dextran-producing strains of W. cibaria. This species has not yet been used as a starter or adjunct culture, but this study reinforces the potential that it has for the food and health industry for the production of functional foods or as a probiotic. Furthermore, analysis of the influence of FMN present in the growth medium, on rib mRNA and riboflavin levels, revealed which mutant strains produce riboflavin without flavin regulation. Moreover, the BAL3C-5 C120T mutant was identified as the highest riboflavin-overproducer. Determination of its chromosomal DNA sequence and that of BAL3C-5, revealed a total identity between the 2 strains except for the C120T mutation at the FMN riboswitch. To our knowledge, this work is the first demonstration that only a single alteration in the genome of a lactic acid bacteria is required for a riboflavin-overproducing phenotype.

microbiology
Real-Time Detection of Riboflavin Production by Lactobacillus plantarum Strains and Tracking of Their Gastrointestinal Survival and Functionality in vitro and in vivo Using mCherry Labeling

Mari Luz Mohedano,Sara Hernández-Recio,Alba Yépez,Teresa Requena,M. Carmen Martínez-Cuesta,Carmen Peláez,Pasquale Russo,Jean Guy LeBlanc,Giuseppe Spano,Rosa Aznar,Paloma López

DOI: https://doi.org/10.3389/fmicb.2019.01748

IF: 5.2

2019-07-31

Frontiers in Microbiology

Abstract:Some strains of lactic acid bacteria (LAB) produce riboflavin, a water-soluble vitamin of the B complex, essential for human beings. Here, we have evaluated riboflavin (B2 vitamin) production by five Lactobacillus plantarum strains isolated from chicha, a traditional maize-based fermented alcoholic beverage from north-western Argentina and their isogenic riboflavin-overproducing derivatives previously selected using roseoflavin. A direct fluorescence spectroscopic detection method to quantify riboflavin production in bacterial culture supernatants has been tested. Comparison of the efficiency for riboflavin fluorescence quantification with and without prior HPLC fractionation showed that the developed method is a rapid and easy test for selection of B2 vitamin-producing strains. In addition, it can be used for quantitative detection of the vitamin production in real time during bacterial growth. On the basis of this and previous analyses, the L. plantarum M5MA1-B2 riboflavin overproducer was selected for in vitro and in vivo studies after being fluorescently labeled by transfer of the pRCR12 plasmid, which encodes the mCherry protein. The labeling did not affect negatively the growth, the riboflavin production nor the adhesion of the strain to Caco-2 cells. Thus, L. plantarum M5MA1-B2[pRCR12] was evaluated for its survival under digestive tract stresses in the presence of microbiota in the dynamic multistage BFBL gut model and in a murine model. After exposure to both models, M5MA1-B2[pRCR12] could be recovered and detected by the pink color of the colonies. The results indicated a satisfactory resistance of the strain to gastric and intestinal stress conditions but a low colonization capability observed both in vitro and in vivo. Overall, L. plantarum M5MA1-B2 could be proposed as a probiotic strain for the development of functional foods.

microbiology
The Probiotic and Immunomodulation Effects of Limosilactobacillus Reuteri RGW1 Isolated from Calf Feces

Kailang Huang,Weibing Shi,Bin Yang,Jiakun Wang

DOI: https://doi.org/10.3389/fcimb.2022.1086861

IF: 6.073

2023-01-01

Frontiers in Cellular and Infection Microbiology

Abstract:IntroductionLimosilactobacillus reuteri is a gut symbiont with multiple remarkable beneficial effects on host health, and members of L. reuteri are valuable probiotic agents. However, L. reuteri showed obvious host specificity.MethodsIn our study, a novel L. reuteri RGW1 was isolated from feces of healthy calves, and its potential as a probiotic candidate were assessed, by combining in vitro, in vivo experiments and genomic analysis.Results and discussionRGW1 was sensitive to all the antibiotics tested, and it did not contain any virulence factor-coding genes. This isolate showed good tolerance to acid (pH 3.0), 0.3% bile salt, and simulated gastric fluid. Moreover, this isolate showed a high hydrophobicity index (73.7 ± 4.6%) and was able to adhere to Caco-2 cells, and antagonize Escherichia coli F5. Treatment of LPS-induced mice with RGW1 elevated TGF-β and IL-10 levels, while RGW1 cell-free supernatant (RCS) decreased TNF-α levels in the sera. Both RGW1 and RCS increased the villus height and villus height/crypt depth ratio of colon. Genomic analysis revealed the mechanism of the probiotic properties described above, and identified the capacity of RGW1 to biosynthesize L-lysine, folate, cobalamin and reuterin de novo. Our study demonstrated the novel bovine origin L. reuteri RGW1 had multiple probiotic characteristics and immunomodulation effects, and provided a deeper understanding of the relationship between these probiotic properties and genetic features.
Characterization of Riboflavin-Producing Strains of Lactobacillus plantarum as Potential Probiotic Candidate through in vitro Assessment and Principal Component Analysis

Bharat Bhushan,Sumit M. Sakhare,Kapil Singh Narayan,Mamta Kumari,Vijendra Mishra,Leon M. T. Dicks

DOI: https://doi.org/10.1007/s12602-020-09696-x

2020-08-18

Probiotics and Antimicrobial Proteins

Abstract:Lactic acid bacteria (LAB) are known for their probiotic properties, but only a few strains produce riboflavin. We evaluated the probiotic properties of four riboflavin-producing strains of Lactobacillus plantarum (BBC33, BBC32A, BIF43, and BBC32B) by using in vitro assessment and carried out multivariate principal component analysis (PCA) to select the best strain. Safety, antioxidant, and exopolysaccharide-producing properties were also studied. Lact. plantarum BBC33 showed better probiotic potential, followed by strain BIF43. Lact. plantarum BBC32A degraded mucin and excluded as a potential probiotic candidate. Lact. plantarum BIF43, BBC33, and BBC32A tolerated simulated gastrointestinal conditions and their overnight cell-free culture supernatants (CFSs, pH 4.0–4.3) inhibited the growth of Escherichia coli AF10, Salmonella Typhi MTCC98, Bacillus cereus NCDC250, and Pseudomonas aeruginosa NCDC105. Lact. plantarum BIF43 and BBC33 did not degrade mucin, adhered to human epithelial colorectal adenocarcinoma Caco-2 cells (22–25%), and aggregated with indicators (30–50%). Moreover, both were non-hemolytic and sensitive to most antibiotics tested. Of the two selected strains, BIF43 showed better exopolysaccharides (EPS) producing phenotype. The CFSs of all strains showed high (85–93%) 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging activity. PCA confirmed the results obtained from in vitro probiotic experiments and supported the selection of Lact. plantarum BIF33 and BBC43, as potential probiotics.

biotechnology & applied microbiology,microbiology
Biotechnological Strategies of Riboflavin Biosynthesis in Microbes

Jia-Rong Zhang,Ying-Ying Ge,Pin-He Liu,Ding-Tao Wu,Hong-Yan Liu,Hua-Bin Li,Harold Corke,Ren-You Gan

DOI: https://doi.org/10.1016/j.eng.2021.03.018

IF: 12.834

2021-05-01

Engineering

Abstract:Riboflavin is an essential micronutrient for humans and must be obtained exogenously from foods or supplements. Numerous studies have suggested a major role of riboflavin in the prevention and treatment of various diseases. There are mainly three strategies for riboflavin synthesis, including total chemical synthesis, chemical semi-synthesis, and microbial fermentation, the latter being currently the most promising strategy. In recent years, flavinogenic microbes have attracted increasing attention. Fungi, including Eremothecium ashbyii and Ashbya gossypii, and bacteria, including Bacillus subtilis, Escherichia coli, and lactic acid bacteria, are ideal cell factories for riboflavin overproduction. Thus they are good candidates for enhancing the level of riboflavin in fermented foods or designing novel riboflavin bio-enriched foods with improved nutritional value and/or beneficial properties for human health. This review briefly describes the role of riboflavin in human health and the historical process of its industrial production, and then highlights riboflavin biosynthesis in bacteria and fungi, and finally summarizes the strategies for riboflavin overproduction based on both the optimization of fermentation conditions and the development of riboflavin-overproducing strains via chemical mutagenesis and metabolic engineering. Overall, this review provides an updated understanding of riboflavin biosynthesis and can promote the research and development of fermented food products rich in riboflavin.

engineering, multidisciplinary
In situ riboflavin fortification of different kefir-like cereal-based beverages using selected Andean LAB strains

Alba Yépez,Pasquale Russo,Giuseppe Spano,Iuliia Khomenko,Franco Biasioli,Vittorio Capozzi,Rosa Aznar

DOI: https://doi.org/10.1016/j.fm.2018.08.008

Abstract:Cereal-based functional beverages represent social, economic, and environmental sustainable opportunities to cope with emerging trends in food consumption and global nutrition. Here we report, for the first time, the polyphasic characterization of three cereal-based kefir-like riboflavin-enriched beverages, obtained from oat, maize and barley flours, and their comparison with classical milk-based kefir. The four matrices were successfully fermented with commercial starters: i) milk-kefir and ii) water-kefir, proving the potential of cereal ingredients in the formulation of dairy-like fermented beverages with milk-kefir starter behavior better in these matrices. In the light of their potentiality, seven riboflavin-producing Andean Lactic Acid Bacteria (LAB) were tested for tolerance to food stresses commonly encountered during food fermentation. Moreover, the LAB strains investigated were screened for spontaneous riboflavin overproducing derivatives. Lactobacillus plantarum M5MA1-B2 with outstanding response to stress, was selected to improve riboflavin content in an in situ fortification approach. The combination of L. plantarum M5MA1-B2 riboflavin overproducing strain with milk kefir starter in oat, lead to cover, for one serving of 100 g, 11.4% of Recommended Dietary Allowance (RDA). Besides, addition of L. plantarum M5MA1-B2 improved performance of water kefir in oat and maize matrices. Proton Transfer Reaction Time-of-Flight Mass Spectrometry (PTR-ToF-MS) analysis provided the on-line Volatile Organic Compounds profiles supporting the best combination of starter, LAB and cereal matrix for novel functional foods development.
Bifidobacterium longum subsp. longum BG-L47 boosts growth and activity of Limosilactobacillus reuteri DSM 17938 and its extracellular membrane vesicles

Ludwig Ermann Lundberg,Punya Pallabi Mishra,Peidi Liu,Manuel Mata Forsberg,Eva Sverremark-Ekström,Gianfranco Grompone,Sebastian Håkansson,Caroline Linninge,Stefan Roos

DOI: https://doi.org/10.1128/aem.00247-24

2024-06-19

Applied and Environmental Microbiology

Abstract:ABSTRACT The aim of this study was to identify a Bifidobacterium strain that improves the performance of Limosilactobacillus reuteri DSM 17938. Initial tests showed that Bifidobacterium longum subsp. longum strains boosted the growth of DSM 17938 during in vivo- like conditions. Further characterization revealed that one of the strains, BG-L47, had better bile and acid tolerance compared to BG-L48, as well as mucus adhesion compared to both BG-L48 and the control strain BB536. BG-L47 also had the capacity to metabolize a broad range of carbohydrates and sugar alcohols. Mapping of glycoside hydrolase (GH) genes of BG-L47 and BB536 revealed many GHs associated with plant-fiber utilization. However, BG-L47 had a broader phenotypic fiber utilization capacity. In addition, B. longum subsp. longum cells boosted the bioactivity of extracellular membrane vesicles (MV) produced by L. reuteri DSM 17938 during co-cultivation. Secreted 5′-nucleotidase (5′NT), an enzyme that converts AMP into the signal molecule adenosine, was increased in MV boosted by BG-L47. The MV exerted an improved antagonistic effect on the pain receptor transient receptor potential vanilloid 1 (TRPV1) and increased the expression of the immune development markers IL-6 and IL-1ß in a peripheral blood mononuclear cell (PBMC) model. Finally, the safety of BG-L47 was evaluated both by genome safety assessment and in a human safety study. Microbiota analysis showed that the treatment did not induce significant changes in the composition. In conclusion, B. longum subsp. longum BG-L47 has favorable physiological properties, can boost the in vitro activity of L. reuteri DSM 17938, and is safe for consumption, making it a candidate for further evaluation in probiotic studies. IMPORTANCE By using probiotics that contain a combination of strains with synergistic properties, the likelihood of achieving beneficial interactions with the host can increase. In this study, we first performed a broad screening of Bifidobacterium longum subsp. longum strains in terms of synergistic potential and physiological properties. We identified a superior strain, BG-L47, with favorable characteristics and potential to boost the activity of the known probiotic strain Limosilactobacillus reuteri DSM 17938. Furthermore, we demonstrated that BG-L47 is safe for consumption in a human randomized clinical study and by performing a genome safety assessment. This work illustrates that bacteria–bacteria interactions differ at the strain level and further provides a strategy for finding and selecting companion strains of probiotics.

microbiology,biotechnology & applied microbiology
A Novel Bifidobacterium longum ssp. longum Strain with Pleiotropic Effects

Merle Rätsep,Kalle Kilk,Mihkel Zilmer,Liina Kuus,Epp Songisepp

DOI: https://doi.org/10.3390/microorganisms12010174

IF: 4.5

2024-01-15

Microorganisms

Abstract:Postbiotics are gaining increasing interest among the scientific community as well as at the level of food processing enterprises. The aim of this preliminary study was to characterise the metabolic diversity of a novel Bifidobacterium longum strain, BIOCC 1719, of human origin. The change after 24 h cultivation in three media was assessed using a metabolomic approach. Milk-based substrates favoured the activity of the strain, promoting the production of B vitamins, essential amino acids, bile acids, and fatty acids. Vitamins B1, B2, B6, B7, and B12 (with an average increase of 20–30%) were produced in both whole milk and whey; the increased production in the latter was as high as 100% for B7 and 744% for B12. The essential amino acids methionine and threonine were produced (>38%) in both milk and whey, and there was an increased production of leucine (>50%) in milk and lysine (126%) in whey. Increases in the content of docosahexaenoic acid (DHA) by 20%, deoxycholic acid in milk and whey (141% and 122%, respectively), and cholic acid (52%) in milk were recorded. During the preliminary characterisation of the metabolic diversity of the novel B. longum strain, BIOCC 1719, we identified the bioactive compounds produced by the strain during fermentation. This suggests its potential use as a postbiotic ingredient to enrich the human diet.

microbiology
A novel strain of acetic acid bacteria Gluconobacter oxydans FBFS97 involved in riboflavin production

Abeer Essam Noman,Naif S Al-Barha,Abdul-Aziz M Sharaf,Qais Ali Al-Maqtari,Amani Mohedein,Hammad Hamed Hammad Mohammed,Fusheng Chen

DOI: https://doi.org/10.1038/s41598-020-70404-4

2020-08-11

Abstract:A novel bacterial strain of acetic acid bacteria capable of producing riboflavin was isolated from the soil sample collected in Wuhan, China. The isolated strain was identified as Gluconobacter oxydans FBFS97 based on several phenotype characteristics, biochemicals tests, and 16S rRNA gene sequence conducted. Furthermore, the complete genome sequencing of the isolated strain has showed that it contains a complete operon for the biosynthesis of riboflavin. In order to obtain the maximum concentration of riboflavin production, Gluconobacter oxydans FBFS97 was optimized in shake flask cultures through response surface methodology employing Plackett-Burman design (PBD), and Central composite design (CCD). The results of the pre-experiments displayed that fructose and tryptone were found to be the most suitable sources of carbon and nitrogen for riboflavin production. Then, PBD was conducted for initial screening of eleven minerals (FeSO4, FeCl3, KH2PO4, K2HPO4, MgSO4, ZnSO4, NaCl, CaCl2, KCl, ZnCl2, and AlCl3.6H2O) for their significances on riboflavin production by Gluconobacter oxydans strain FBFS97. The most significant variables affecting on riboflavin production are K2HPO4 and CaCl2, the interaction affects and levels of these variables were optimized by CCD. After optimization of the medium compositions for riboflavin production were determined as follows: fructose 25 g/L, tryptone 12.5 g/L, K2HPO4 9 g/L, and CaCl2 0.06 g/L with maximum riboflavin production 23.24 mg/L.
Riboflavin overproduction from diverse feedstocks with engineered Corynebacterium glutamicum

Fernando Pérez-García,Luciana Fernandes Brito,Thea Isabel Bakken,Trygve Brautaset

DOI: https://doi.org/10.1088/1758-5090/ad628e

2024-07-13

Biofabrication

Abstract:Riboflavin overproduction by Corynebacterium glutamicum was achieved by screening synthetic operons, enabling fine-tuned expression of the riboflavin biosynthetic genes ribGCAH. The synthetic operons were designed by means of predicted translational initiation rates of each open reading frame, with the best-performing selection enabling riboflavin overproduction without negatively affecting cell growth. Overexpression of the fructose-1,6-bisphosphatase (fbp) and 5-phosphoribosyl 1-pyrophosphate aminotransferase (purF) encoding genes was then done to redirect the metabolic flux towards the riboflavin precursors. The resulting strain produced 8.3 g/L of riboflavin in glucose-based fed-batch fermentations, which is the highest reported riboflavin titer with C. glutamicum. Further genetic engineering enabled both xylose and mannitol utilization by C. glutamicum, and we demonstrated riboflavin overproduction with the xylose-rich feedstocks rice husk hydrolysate and spent sulfite liquor, and the mannitol-rich feedstock brown seaweed hydrolysate. Remarkably, rice husk hydrolysate provided 30% higher riboflavin yields compared to glucose in the bioreactors.

engineering, biomedical,materials science, biomaterials
[Development of biotechnology of fermented milk product with Lactobacillus reuteri LR1 and the evaluation of its functional property in experiment in vitro and in vivo]

V F Semenikhina,I V Rozhkova,A V Begunova,T V Fedorova,T I Shirshova

DOI: https://doi.org/10.24411/0042-8833-2018-10053

Abstract:In this article the biotechnology of the dairy product based on the probiotic strain of Lactobacillus reuteri LR1 is presented. The following conditions of milk fermentation were screened: fermentation by monoculture of Lactobacillus reuteri LR1, fermentation by monoculture of Lactobacillus reuteri LR1 with addition of yeast extract as growth-promoting factor, and combined fermentation by Lactobacillus reuteri LR1, Lactobacillus helveticus NK1 and Streptococcus thermophilus (HTC). It had been demonstrated that after 8 hours of cultivation the number of Lactobacillus reuteri LR1 cells in the monoculture with introduced yeast extract was up to 5,9×108 CFU/cm3 whereas cell count for the monoculture without yeast extract introduction was 1,6×107 CFU/cm3. The optimized biotechnological parameters of the dairy product fermentation, which provided the required Lactobacillus reuteri LR1 cell count, were as follows: Lactobacillus reuteri LR1 starter dosage of 6%, HTC starter dosage of 3-4%, fermentation temperature of 37±1 °C, and fermentation duration of 6 hours. The developed product possessed an apparent antagonistic activity against test-cultures of such pathogenic and opportunistic microorganisms as E. coli ATCC 25922, Salmonella typhimurium, Staphylococcus aureus ATCC 6538 and Klebsiella pneumoniae. The survival of the test-cultures cultivated with the obtained dairy product on the first cultivation day was from 36 to 46% and on the second - from 8 to 20%, in comparison with the pure test-cultures. The investigation of the functional properties of the obtained dairy product was carried out by the single-factor experiment with the albino Wistar rat-stock (initial body weight 160±10 g, n=10 in each group). Its positive effect on the rats' microbiome composition and lipid exchange indices has been demonstrated. It had been shown that the administration of the obtained dairy product in the rats' diet (5 ml per day per os) during 30 days didn't cause any abnormalities in the health status and behavior of the laboratory animals of spf-category. The number and distribution of leucocytes and lymphocytes, and granulocytes in all rats' populations (intact, control and treatment) were within the normal range. Upon the introduction of the developed dairy product into the rats' diet, the increased levels of bifidobacteria, lactic acid bacteria and typical for normal rats' microflora enterobacteria were observed in the rats' microbiome. As for the biochemical indices that characterize rats' lipid metabolism, the rats consuming fermented dairy products (control and treatment) demonstrated statistically significant reduction of blood serum cholesterol level compared to the intact rat group; additionally the rats consuming the developed in this study dairy product (treatment) demonstrated statistically significant reduction of blood serum triglyceride level compared to the intact rats. Utilized in this study Lactobacillus reuteri LR1 is the first strain that was purified in Russia and characterized as useful for manufacturing of the probiotic food products, since currently only Lactobacillus reuteri strains of foreign origin can be seen on the market.
From Brown Seaweed to a Sustainable Microbial Feedstock for the Production of Riboflavin

Fernando Pérez-García,Vivien Jessica Klein,Luciana Fernandes Brito,Trygve Brautaset

DOI: https://doi.org/10.3389/fbioe.2022.863690

IF: 5.7

2022-04-12

Frontiers in Bioengineering and Biotechnology

Abstract:The increasing global demand for food and energy production encourages the development of new production strategies focused on sustainability. Often, microbial bioprocesses rely on food or feed competitive feedstocks; hence, there is a trending need for green substrates. Here, we have proven the potential of brown seaweed biomass as microbial feedstock on account of its content of mannitol and the glucose polymer laminarin. Our host, Corynebacterium glutamicum , was engineered to enable access to mannitol as a carbon source through the heterologous expression of the mannitol-specific phosphotransferase system and the mannitol-1-phosphate-5-dehydrogenase from Bacillus subtilis. Overproduction of riboflavin was coupled with mannitol and glucose consumption via constitutive overexpression of the biosynthetic riboflavin operon ribGCAH from C. glutamicum . Brown seaweed extract and brown seaweed hydrolysate from Laminaria hyperborea , containing mannitol and glucose, were used as a carbon source for flask and bioreactor fermentations. In a seaweed-based fed-batch fermentation, the riboflavin final titer, yield, and volumetric productivity values of 1,291.2 mg L −1 , 66.1 mg g −1 , and 17.2 mg L −1 h −1 , respectively, were achieved.

multidisciplinary sciences
Limosilactobacillus fermentum Strain 3872: Antibacterial and Immunoregulatory Properties and Synergy with Prebiotics against Socially Significant Antibiotic-Resistant Infections of Animals and Humans

Vyacheslav M Abramov,Igor V Kosarev,Andrey V Machulin,Tatiana V Priputnevich,Irina O Chikileva,Evgenia I Deryusheva,Tatiana N Abashina,Almira D Donetskova,Alexander N Panin,Vyacheslav G Melnikov,Nataliya E Suzina,Ilia N Nikonov,Marina V Selina,Valentin S Khlebnikov,Vadim K Sakulin,Raisa N Vasilenko,Vladimir A Samoilenko,Vladimir N Uversky,Andrey V Karlyshev

DOI: https://doi.org/10.3390/antibiotics11101437

2022-10-19

Abstract:Limosilactobacillus fermentum strain 3872 (LF3872) was originally isolated from the breast milk of a healthy woman during lactation and the breastfeeding of a child. The high-quality genome sequencing of LF3872 was performed, and a gene encoding a unique bacteriocin was discovered. It was established that the bacteriocin produced by LF3872 (BLF3872) belongs to the family of cell-wall-degrading proteins that cause cell lysis. The antibacterial properties of LF3872 were studied using test cultures of antibiotic-resistant Gram-positive and Gram-negative pathogens. Gram-positive pathogens (Staphylococcus aureus strain 8325-4 and S. aureus strain IIE CI-SA 1246) were highly sensitive to the bacteriolytic action of LF3872. Gram-negative pathogens (Escherichia coli, Salmonella strains, and Campylobacter jejuni strains) were more resistant to the bacteriolytic action of LF3872 compared to Gram-positive pathogens. LF3872 is a strong co-aggregator of Gram-negative pathogens. The cell-free culture supernatant of LF3872 (CSLF3872) induced cell damage in the Gram-positive and Gram-negative test cultures and ATP leakage. In the in vitro experiments, it was found that LF3872 and Actigen prebiotic (Alltech Inc., Nicholasville, KY, USA) exhibited synergistic anti-adhesive activity against Gram-negative pathogens. LF3872 has immunoregulatory properties: it inhibited the lipopolysaccharide-induced production of proinflammatory cytokines IL-8, IL-1β, and TNF-α in a monolayer of Caco-2 cells; inhibited the production of IL-12 and stimulated the production of IL-10 in immature human dendritic cells; and stimulated the production of TGF-β, IFN-γ, and IgA in the immunocompetent cells of intestinal Peyer's patches (PPs) in mice. These results indicate the possibility of creating a synbiotic based on LF3872 and a prebiotic derived from Saccharomyces cerevisiae cell wall components. Such innovative drugs and biologically active additives are necessary for the implementation of a strategy to reduce the spread of antibiotic-resistant strains of socially significant animal and human infections.
Structure of a peptide antifreeze and mechanism of adsorption to ice.

A. Devries,Y. Lin

DOI: https://doi.org/10.1016/0005-2795(77)90395-6

1977-12-20

Biochimica et Biophysica Acta

Abstract:
Limosilactobacillus fermentum Strains as Novel Probiotic Candidates to Promote Host Health Benefits and Development of Biotherapeutics: A Comprehensive Review

Micaelle Oliveira de Luna Freire,José Patrocínio Ribeiro Cruz Neto,Deborah Emanuelle de Albuquerque Lemos,Thatyane Mariano Rodrigues de Albuquerque,Estefânia Fernandes Garcia,Evandro Leite de Souza,José Luiz de Brito Alves

DOI: https://doi.org/10.1007/s12602-024-10235-1

2024-02-24

Probiotics and Antimicrobial Proteins

Abstract:Fruits and their processing by-products are sources of potentially probiotic strains. Limosilactobacillus ( L. ) fermentum strains isolated from fruit processing by-products have shown probiotic-related properties. This review presents and discusses the results of the available studies that evaluated the probiotic properties of L. fermentum in promoting host health benefits, their application by the food industry, and the development of biotherapeutics. The results showed that administration of L. fermentum for 4 to 8 weeks promoted host health benefits in rats, including the modulation of gut microbiota, improvement of metabolic parameters, and antihypertensive, antioxidant, and anti-inflammatory effects. The results also showed the relevance of L. fermentum strains for application in the food industry and for the formulation of novel biotherapeutics, especially nutraceuticals. This review provides evidence that L. fermentum strains isolated from fruit processing by-products have great potential for promoting host health and indicate the need for a translational approach to confirm their effects in humans using randomized, double-blind, placebo-controlled trials.

biotechnology & applied microbiology,microbiology
Metabolic engineering of Escherichia coli for the production of riboflavin

Zhenquan Lin,Zhibo Xu,Yifan Li,Zhiwen Wang,Tao Chen,Xueming Zhao

DOI: https://doi.org/10.1186/s12934-014-0104-5

IF: 6.352

2014-07-16

Microbial Cell Factories

Abstract:BackgroundRiboflavin (vitamin B2), the precursor of the flavin cofactors flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), is used commercially as an animal feed supplement and food colorant. E. coli is a robust host for various genetic manipulations and has been employed for efficient production of biofuels, polymers, amino acids, and bulk chemicals. Thus, the aim of this study was to understand the metabolic capacity of E. coli for the riboflavin production by modification of central metabolism, riboflavin biosynthesis pathway and optimization of the fermentation conditions.ResultsThe basic producer RF01S, in which the riboflavin biosynthesis genes ribABDEC from E. coli were overexpressed under the control of the inducible trc promoter, could accumulate 229.1 mg/L of riboflavin. Further engineering was performed by examining the impact of expression of zwf (encodes glucose 6-phosphate dehydrogenase) and gnd (encodes 6-phosphogluconate dehydrogenase) from Corynebacterium glutamicum and pgl (encodes 6-phosphogluconolactonase) from E. coli on riboflavin production. Deleting pgi (encodes glucose-6-phosphate isomerase) and genes of Entner-Doudoroff (ED) pathway successfully redirected the carbon flux into the oxidative pentose phosphate pathway, and overexpressing the acs (encodes acetyl-CoA synthetase) reduced the acetate accumulation. These modifications increased riboflavin production to 585.2 mg/L. By further modulating the expression of ribF (encodes riboflavin kinase) for reducing the conversion of riboflavin to FMN in RF05S, the final engineering strain RF05S-M40 could produce 1036.1 mg/L riboflavin in LB medium at 37°C. After optimizing the fermentation conditions, strain RF05S-M40 produced 2702.8 mg/L riboflavin in the optimized semi-defined medium, which was a value nearly 12-fold higher than that of RF01S, with a yield of 137.5 mg riboflavin/g glucose.ConclusionsThe engineered strain RF05S-M40 has the highest yield among all reported riboflavin production strains in shake flask culture. This work collectively demonstrates that E. coli has a potential to be a microbial cell factory for riboflavin bioproduction.

biotechnology & applied microbiology
Production of vitamin B2 (riboflavin) by Bacillus subtilis

Ronghao Chu,Rui Li,Chen Wang,Rui Ban

DOI: https://doi.org/10.1002/jctb.7017

IF: 3.709

2022-01-05

Journal of Chemical Technology and Biotechnology

Abstract:Riboflavin is one of the main micronutrients required for the human body for cellular respiration. It is the precursor of flavin mononucleotide and flavin adenine dinucleotide coenzymes crucial for the production of energy. The development of biotechnology has given rise to microbial procedures that strongly compete with the chemical synthesis approach and hence the fermentation process of riboflavin by microorganisms was initiated. Therefore, the main aim of this review is to investigate the production of riboflavin by Bacillus subtilis fermentation. The introduction of the microbial synthesis method has found that regulatory and structural genes involved in the synthesis of vitamin B2 are overexpressed, which has eventually enhanced the strain productivity and production of the vitamin via industrial fermentation. Using B. subtilis to synthesize riboflavin can reduce the production cost and increase the yield of riboflavin. The emergence of microbial synthesis methods has effectively increased the yield of riboflavin, and the study of the process of riboflavin synthesis by B. subtilis is of great significance for improving production, reducing costs and using renewable raw materials. © 2021 Society of Chemical Industry (SCI).

engineering, chemical,biotechnology & applied microbiology, environmental,chemistry, multidisciplinary
OPTIMIZATION OF RIBOFLAVIN PRODUCTION USING BACILLUS CEREUS HDS07: A STRAIN ISOLATED FROM AGARICUS BISPORUS

Hemalatha M,Subathra Devi C

DOI: https://doi.org/10.55251/jmbfs.9066

2023-02-01

Abstract:The current study focused on the production and optimization of riboflavin from Bacillus cereus, a strain isolated from Agaricus bisporus. Seven different strains were isolated from Agaricus bisporus and screened for riboflavin production. Among the 7 strains, only 4 strains were identified as riboflavin producers by riboflavin assay medium (RAM). To determine the potency of the strains, selected strains were exposed to roseoflavin – an analogue of riboflavin. The potent strain was identified through morphological, biochemical, and molecular characterization and the strain name was designated as HDS07. Estimation of riboflavin was done by UV Spectrophotometry. Riboflavin production was done in Chemically Defined Medium (CDM) and De Man, Rogosa and Sharpe agar (MRS) using a strain Bacillus cereus HDS07. To enhance riboflavin production, the medium was optimized with different parameters like carbon, nitrogen sources, pH, temperature, and inoculum size. The potent strain HDS07 was identified as Bacillus cereus by 16S rDNA sequencing and NCBI-Gen Bank accession number - MK177597 was obtained. Riboflavin production from Bacillus cereus-HDS07 was more in the MRS medium than that of CDM. It was found to be 2.97 mg/L and 1.8 mg/L correspondingly. The maximum riboflavin (3.48 mg/L) was obtained from Bacillus cereus-HDS07 under the culture conditions; glucose, glycine, pH-6, 30°C, and 3% inoculum size. The current study emphasizes that the isolated potent strain Bacillus cereus-HDS07 from Agaricus bisporus could be used as a starter for the industrial production of riboflavin.
Probiotic Characteristics of Lactiplantibacillus plantarum CECT 9435 and Its Survival and Competitive Properties Under Simulated Conditions of the Child Gut Microbiota

Teresa Requena,M. Carmen Martínez-Cuesta,Rosa Aznar,M. Luz Mohedano,Paloma López,Patricia Ruas-Madiedo

DOI: https://doi.org/10.1007/s12602-024-10280-w

2024-05-09

Probiotics and Antimicrobial Proteins

Abstract:Probiotics are valuable microorganisms effective in reducing malnutrition-related infections in children. In this work, a collection of lactobacilli strains representative of traditional Andean fermented beverages was in vitro screened for their capability to survive the gastrointestinal transit, to adhere to the intestinal epithelium and to compete under simulated conditions of the child gut microbiota. The results allowed the selection of the riboflavin overproducing strain Lactiplantibacillus plantarum CECT 9435 based on its good rate of survival under in vitro gastrointestinal conditions when included in a food matrix representing the fortified food supplement Incaparina. The strain also showed good adhesion to HT29 cells producing mucus and outstanding performance in E. coli competition for the adhesion to this epithelial cell line. L. plantarum CECT 9435 gut performance was also evaluated in the child intestinal microbiota simulated in a dynamic gut model (BFBL simulator). The viability of the probiotic candidate in the gut conditions was high during the 7-day intervention period, reaching over 1 × 10 7 counts in each of the reactors simulating the three colonic regions. The transient viability of L. plantarum CECT 9435 within the child gut microbiota and its adhesion capacity to intestinal cells could facilitate the strain potential benefits as probiotic added to fortified supplementary foods destined to malnourished children.

biotechnology & applied microbiology,microbiology

A randomized trial of extra‐amniotic saline infusion versus laminaria for cervical ripening

Self-assembling materials for therapeutic delivery.

A methodology for the selection and characterization of riboflavin-overproducing Weissella cibaria strains after treatment with roseoflavin

Real-Time Detection of Riboflavin Production by Lactobacillus plantarum Strains and Tracking of Their Gastrointestinal Survival and Functionality in vitro and in vivo Using mCherry Labeling

The Probiotic and Immunomodulation Effects of Limosilactobacillus Reuteri RGW1 Isolated from Calf Feces

Characterization of Riboflavin-Producing Strains of Lactobacillus plantarum as Potential Probiotic Candidate through in vitro Assessment and Principal Component Analysis

Biotechnological Strategies of Riboflavin Biosynthesis in Microbes

In situ riboflavin fortification of different kefir-like cereal-based beverages using selected Andean LAB strains

Bifidobacterium longum subsp. longum BG-L47 boosts growth and activity of Limosilactobacillus reuteri DSM 17938 and its extracellular membrane vesicles

A Novel Bifidobacterium longum ssp. longum Strain with Pleiotropic Effects

A novel strain of acetic acid bacteria Gluconobacter oxydans FBFS97 involved in riboflavin production

Riboflavin overproduction from diverse feedstocks with engineered Corynebacterium glutamicum

[Development of biotechnology of fermented milk product with Lactobacillus reuteri LR1 and the evaluation of its functional property in experiment in vitro and in vivo]

From Brown Seaweed to a Sustainable Microbial Feedstock for the Production of Riboflavin

Limosilactobacillus fermentum Strain 3872: Antibacterial and Immunoregulatory Properties and Synergy with Prebiotics against Socially Significant Antibiotic-Resistant Infections of Animals and Humans

Structure of a peptide antifreeze and mechanism of adsorption to ice.

Limosilactobacillus fermentum Strains as Novel Probiotic Candidates to Promote Host Health Benefits and Development of Biotherapeutics: A Comprehensive Review

Metabolic engineering of Escherichia coli for the production of riboflavin

Production of vitamin B2 (riboflavin) by Bacillus subtilis

OPTIMIZATION OF RIBOFLAVIN PRODUCTION USING BACILLUS CEREUS HDS07: A STRAIN ISOLATED FROM AGARICUS BISPORUS

Probiotic Characteristics of Lactiplantibacillus plantarum CECT 9435 and Its Survival and Competitive Properties Under Simulated Conditions of the Child Gut Microbiota